Plouvier, Bertrand’s team published research in Heterocycles in 1991-04-01 | 72054-60-5

Heterocycles published new progress about 72054-60-5. 72054-60-5 belongs to class thiazole, and the molecular formula is C7H10N2O2S, Application of C7H10N2O2S.

Plouvier, Bertrand; Bailly, Christian; Houssin, Raymond; Henichart, Jean Pierre published the artcile< Synthesis of two new thiazole-containing oligopeptides as potential DNA minor groove binding analogs of netropsin>, Application of C7H10N2O2S, the main research area is netrospin thiazole analog DNA binding.

On the basis of previous studies on synthetic models related to the antibiotic agents netropsin and distamycin A, the design and synthesis of two potential DNA minor groove ligands I and II are described. I and II were prepared by liquid-phase peptide synthesis from the key compounds Et 2-amino-5-methylthiazole-4-carboxylate and Et 2-aminothiazole-5-carboxylate, resp.

Heterocycles published new progress about 72054-60-5. 72054-60-5 belongs to class thiazole, and the molecular formula is C7H10N2O2S, Application of C7H10N2O2S.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Hasgur, Suheyla’s team published research in Cytotherapy in 2021-05-31 | 2591-17-5

Cytotherapy published new progress about Adhesion G protein-coupled receptor E1 Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 2591-17-5 belongs to class thiazole, and the molecular formula is C11H8N2O3S2, Safety of (S)-2-(6-Hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid.

Hasgur, Suheyla; Desbourdes, Laura; Relation, Theresa; Overholt, Kathleen M.; Stanek, Joseph R.; Guess, Adam J.; Yu, Minjun; Patel, Pratik; Roback, Linda; Dominici, Massimo; Otsuru, Satoru; Horwitz, Edwin M. published the artcile< Splenic macrophage phagocytosis of intravenously infused mesenchymal stromal cells attenuates tumor localization>, Safety of (S)-2-(6-Hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid, the main research area is mesenchymal stromal cell splenic macrophage phagocytosis tumor localization; cancer cell therapy; lentiviral transduction; mesenchymal stromal cells (MSCs); phagocytosis; splenic macrophage; stem cell transplantation; tumor homing.

Mesenchymal stromal cells (MSCs) possess remarkable tumor tropism, making them ideal vehicles to deliver tumor-targeted therapeutic agents; however, their value in clin. medicine has yet to be realized. A barrier to clin. utilization is that only a small fraction of infused MSCs ultimately localize to the tumor. In an effort to overcome this obstacle, we sought to enhance MSC trafficking by focusing on the factors that govern MSC arrival within the tumor microenvironment. Our findings show that MSC chemoattraction is only present in select tumors, including osteosarcoma, and that the chemotactic potency among similar tumors varies substantially. Using an osteosarcoma xenograft model, we show that human MSCs traffic to the tumor within several hours of infusion. After arrival, MSCs are observed to localize in clusters near blood vessels and MSC-associated bioluminescence signal intensity is increased, suggesting that the seeded cells expand after engraftment. However, our studies reveal that a significant portion of MSCs are eliminated en route by splenic macrophage phagocytosis, effectively limiting the number of cells available for tumor engraftment. To increase MSC survival, we transiently depleted macrophages with liposomal clodronate, which resulted in increased tumor localization without substantial reduction in tumor-associated macrophages. Our data suggest that transient macrophage depletion will significantly increase the number of MSCs in the spleen and thus improve MSC localization within a tumor, theor. increasing the ED of an anti-cancer agent. This strategy may subsequently improve the clin. efficacy of MSCs as vehicles for the tumor-directed delivery of therapeutic agents.

Cytotherapy published new progress about Adhesion G protein-coupled receptor E1 Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 2591-17-5 belongs to class thiazole, and the molecular formula is C11H8N2O3S2, Safety of (S)-2-(6-Hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Inouye, Satoshi’s team published research in Protein Expression and Purification in 2020-07-31 | 2591-17-5

Protein Expression and Purification published new progress about Absorption. 2591-17-5 belongs to class thiazole, and the molecular formula is C11H8N2O3S2, Category: thiazole.

Inouye, Satoshi; Sahara-Miura, Yuiko; Nakamura, Mitsuhiro; Hosoya, Takamitsu published the artcile< Expression, purification, and characterization of recombinant apoPholasin>, Category: thiazole, the main research area is apoPholasin glutathione transferase coelenterazine reactive oxygen species oxidation; Coelenteramide; Coelenteramine; Dehydrocoelenterazine; Photoproteins; Reactive oxygen.

Pholasin is a reactive oxygen-sensitive photoprotein that consists of an apoprotein (apoPholasin) and an unknown chromophore. The preferred human codon-optimized apoPholasin gene was transiently expressed in mammalian cells and apoPholasin was detected using an anti-recombinant apoPholasin antibody. For the first time, we found that apoPholasin secreted into the culture medium could catalyze the oxidation of coelenterazine (CTZ, a luciferin) to produce continuous luminescence. The fusion protein of apoPholasin and glutathione S-transferase (GST-apoPholasin) was successfully expressed as a soluble form in bacterial cells using the cold induction system. The purified GST-apoPholasin also had luminescence activity with CTZ, showing the bioluminescence emission peak at 461 nm, and the resultant product showed purple blue fluorescence under 365 nm light. Unexpectedly, the main oxidation product of CTZ was identified as coelenteramine (CTM), not coelenteramide (CTMD).

Protein Expression and Purification published new progress about Absorption. 2591-17-5 belongs to class thiazole, and the molecular formula is C11H8N2O3S2, Category: thiazole.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Komanova, E’s team published research in Journal of Chromatography in 1971 | 10574-69-3

Journal of Chromatography published new progress about Linear free energy relationship. 10574-69-3 belongs to class thiazole, and the molecular formula is C10H9NOS2, SDS of cas: 10574-69-3.

Komanova, E.; Knoppova, V.; Koman, V.; Malinova, A. published the artcile< Gas chromatography of isothiocyanates and 3-substituted rhodanines>, SDS of cas: 10574-69-3, the main research area is retention time isothiocyanates; gas chromatog rhodanines.

Retention times in the gas chromatog. separation of 3-substituted alkyl- or arylrhodanines were 5.9 min higher than for the corresponding isothiocyanates, indicating a successful separation of a mixture of these compounds by gas-liquid chromatog. For example, the retention time observed for 4-ethoxyphenyl isothiocyanate was 18.03 min while that of 4-(ethoxyphenyl)-3-rhodanine (I) was 24.02 min. A plot of Hammett constants vs. retention times for 4-substituted isothiocyanates and 3-substituted rhodanines was not linear. Electron-releasing substituents shifted their retention times to lower values while electron-withdrawing substituents had the opposite effect.

Journal of Chromatography published new progress about Linear free energy relationship. 10574-69-3 belongs to class thiazole, and the molecular formula is C10H9NOS2, SDS of cas: 10574-69-3.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Komiyama, Masato’s team published research in Organic Process Research & Development in 2018-09-21 | 20582-55-2

Organic Process Research & Development published new progress about Arylation. 20582-55-2 belongs to class thiazole, and the molecular formula is C7H9NO2S, Electric Literature of 20582-55-2.

Komiyama, Masato; Tsuchiya, Hideyoshi; Teramoto, Mitsuru; Yajima, Naoki; Kurokawa, Masayuki; Minamizono, Kunio; Tsuchiya, Naoki; Kato, Yoshiaki; Sato, Yoshinori; Dohi, Masahiko published the artcile< Process Development of Febuxostat Using Palladium- and Copper-Catalyzed C-H Arylation>, Electric Literature of 20582-55-2, the main research area is Febuxostat process synthesis palladium copper catalyzed arylation thiazole bromoarene.

There is significant interest in the development of process routes for active pharmaceutical ingredients using C-H arylation methodol. An efficient and practical synthetic route for febuxostat, which is the first non-purine-type xanthine oxidase inhibitor, was established via palladium- and copper-catalyzed C-H arylation of thiazole with aryl bromide. The catalyst loading was reduced to 0.1 mol % for the intermol. C-H arylation, and a three-step synthesis produced febuxostat in 89% overall yield with excellent selectivity.

Organic Process Research & Development published new progress about Arylation. 20582-55-2 belongs to class thiazole, and the molecular formula is C7H9NO2S, Electric Literature of 20582-55-2.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Wu, Yikang’s team published research in Journal of Organic Chemistry in 2004-11-12 | 171877-39-7

Journal of Organic Chemistry published new progress about Aldol condensation, stereoselective. 171877-39-7 belongs to class thiazole, and the molecular formula is C10H11NS2, SDS of cas: 171877-39-7.

Wu, Yikang; Sun, Ya-Ping; Yang, Yong-Qing; Hu, Qi; Zhang, Qi published the artcile< Removal of thiazolidinethione auxiliaries with benzyl alcohol mediated by DMAP. [Erratum to document cited in CA141:295695]>, SDS of cas: 171877-39-7, the main research area is erratum acylthiazolidinethione benzyl alc substitution DMAP; benzyl ester preparation erratum; DMAP substitution mediator erratum.

All of the starting thiazolidine-thiones (compounds 1, 1′, 3, 5, 7, 9, 11, 13, 13′, 15, 17, 19, 21, 23, 27, and 29) are yellow oils, not colorless ones.

Journal of Organic Chemistry published new progress about Aldol condensation, stereoselective. 171877-39-7 belongs to class thiazole, and the molecular formula is C10H11NS2, SDS of cas: 171877-39-7.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Lakhan, R’s team published research in Farmaco, Edizione Scientifica in 1986-10-31 | 57493-24-0

Farmaco, Edizione Scientifica published new progress about Local anesthetics. 57493-24-0 belongs to class thiazole, and the molecular formula is C9H7N3O2S, Safety of 2-Amino-4-(3-nitrophenyl)thiazole.

Lakhan, R.; Rai, B. J. published the artcile< Local anesthetics. IV. Synthesis and activity of 2-(N-substituted or N,N-disubstituted aminoacetamido)-4- or -4,5-substituted thiazoles>, Safety of 2-Amino-4-(3-nitrophenyl)thiazole, the main research area is local anesthetic aminoacetamidothiazole preparation; thiazole aminoacetamido anesthetic preparation.

I (R = H or Me, R1 and R2 = H or alkyl or NR1R2 = morpholino, R3 = H or m- or p-O2N) were prepared by treatment of the appropriate 2-chloroacetamidothiazole derivative with an appropriate amine. I(R = H, R1 = R2 = iso-Pr, R3 = m-O2N) [105602-34-4] and I (R = Me, R1 = R2 = Pr, R3 = H) [105602-33-3] (as HCl salt) were the most potent local onesthetics in comparison with procaine-HCl. All other I required a similar time n producing onset of anesthesia as procaine.

Farmaco, Edizione Scientifica published new progress about Local anesthetics. 57493-24-0 belongs to class thiazole, and the molecular formula is C9H7N3O2S, Safety of 2-Amino-4-(3-nitrophenyl)thiazole.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Kearney, Patrick C’s team published research in Journal of Organic Chemistry in 1998-01-09 | 57493-24-0

Journal of Organic Chemistry published new progress about Cyclocondensation reaction. 57493-24-0 belongs to class thiazole, and the molecular formula is C9H7N3O2S, Synthetic Route of 57493-24-0.

Kearney, Patrick C.; Fernandez, Monica; Flygare, John A. published the artcile< Traceless Solid-Phase Synthesis of 2-Aminothiazoles>, Synthetic Route of 57493-24-0, the main research area is thiazolamine derivative preparation solid phase; ketone bromo cyclocondensation resin bound thiourea.

2-Aminothiazoles are produced under mild conditions in good yields and with high degrees of purity from a primary amine and an α-bromo ketone. The key to this method is the conversion of a resin-bound amino group to a thiourea using Fmoc-NCS.

Journal of Organic Chemistry published new progress about Cyclocondensation reaction. 57493-24-0 belongs to class thiazole, and the molecular formula is C9H7N3O2S, Synthetic Route of 57493-24-0.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Curreli, Francesca’s team published research in Journal of Medicinal Chemistry in 2015-09-10 | 20582-55-2

Journal of Medicinal Chemistry published new progress about AIDS (disease). 20582-55-2 belongs to class thiazole, and the molecular formula is C7H9NO2S, HPLC of Formula: 20582-55-2.

Curreli, Francesca; Kwon, Young Do; Zhang, Hongtao; Scacalossi, Daniel; Belov, Dmitry S.; Tikhonov, Artur A.; Andreev, Ivan A.; Altieri, Andrea; Kurkin, Alexander V.; Kwong, Peter D.; Debnath, Asim K. published the artcile< Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity>, HPLC of Formula: 20582-55-2, the main research area is antiviral HIV AIDS.

Earlier the authors reported the discovery and design of NBD-556 and their analogs which demonstrated their potential as HIV-1 entry inhibitors. However, progress in developing these inhibitors has been stymied by their CD4-agonist properties, an unfavorable trait for use as drug. Here, the authors demonstrate the successful conversion of a full CD4-agonist (NBD-556) through a partial CD4-agonist (NBD-09027), to a full CD4-antagonist I (NBD-11021) by structure-based modification of the critical oxalamide mid-region, previously thought to be intolerant of modification. I showed unprecedented neutralization breath for this class of inhibitors, with pan-neutralization against a panel of 56 Env-pseudotyped HIV-1 representing diverse subtypes of clin. isolates (IC50 as low as 270 nM). The cocrystal structure of NBD-11021 complexed to a monomeric HIV-1 gp120 core revealed its detail binding characteristics. The study is expected to provide a framework for further development of NBD series as HIV-1 entry inhibitors for clin. application against AIDS.

Journal of Medicinal Chemistry published new progress about AIDS (disease). 20582-55-2 belongs to class thiazole, and the molecular formula is C7H9NO2S, HPLC of Formula: 20582-55-2.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Dutta, Satyajit’s team published research in Pharma Chemica in 2011 | 57493-24-0

Pharma Chemica published new progress about Antibacterial agents. 57493-24-0 belongs to class thiazole, and the molecular formula is C9H7N3O2S, COA of Formula: C9H7N3O2S.

Dutta, Satyajit; Mariappan, G.; Asada, R. K.; Bhuyan, N. R.; Mohanty, J. P. published the artcile< Synthesis and antimicrobial evaluation of aminophenylthiazole derivatives>, COA of Formula: C9H7N3O2S, the main research area is acetophenone thiourea cyclocondensation; amino aryl thiazole preparation antibacterial antifungal.

A new series of 2-aminophenylthiazole derivatives was synthesized and structures were confirmed on the basis of IR, 1H-NMR spectroscopic data. The compounds were screened for antimicrobial activity in vitro by Kirby-Bauer disk diffusion method and the compounds 2-amino-4-(3-nitro/4-chlorophenyl)phenylthiazoles showed promising activity.

Pharma Chemica published new progress about Antibacterial agents. 57493-24-0 belongs to class thiazole, and the molecular formula is C9H7N3O2S, COA of Formula: C9H7N3O2S.

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica